Figure 2.
Functional significance of Rpn10. (A) Dependency scores of Rpn10 across cancers based on CRISPR data sets in the DepMap web portal. A lower chronos score indicates that the gene of interest is essential in a given cell line. Score 0 means the gene is not essential, whereas score –1 is comparable with the median of all panessential genes (red line). (B) The proliferation of the MM.1S and ANBL6 inducible Rpn10-shRNA KD cell lines were analyzed using a CTG assay (mean ± SD, n = 3) when cultured with or without Dox. Inducible KD of Rpn10 was achieved using pTRIPz-mCherry vector containing Rpn10-shRNA or scramble control. (C) The stable adding back cell line was achieved when AMO1 Rpn10-iKO cells were transfected with lentivirus-packaged V5-tagged Rpn10 plasmid or empty plasmid (pEV), followed by blasticidin selection. Cell proliferation was measured by a CTG assay (mean ± SD, n = 3). Immunoblot shows the expression levels of Rpn10. Human AMO1 Rpn10-shRNA KD cells (D) or MM.1S Rpn10-shRNA KD cells (E-F) were subcutaneously inoculated into CB17 severe combined immunodeficiency mice. In the early prevention model (D-E), a cohort of mice was treated with an irradiated 0.0625% Dox diet (1-6 mg of Dox per mouse per day) continuously starting 5 days after injection. In the late prevention model (n = 10) (F), mice were treated with an irradiated 0.0625% Dox diet after the tumor became visible and the volume was ∼100 mm3. The average and standard deviation of tumor volume (mm3) are shown vs the time when the tumor was measured (mean tumor volume ± SD). Kaplan-Meier plots show survival in mice (right). Internal blot shows Rpn10 expression of the tumor lysates.

Functional significance of Rpn10. (A) Dependency scores of Rpn10 across cancers based on CRISPR data sets in the DepMap web portal. A lower chronos score indicates that the gene of interest is essential in a given cell line. Score 0 means the gene is not essential, whereas score –1 is comparable with the median of all panessential genes (red line). (B) The proliferation of the MM.1S and ANBL6 inducible Rpn10-shRNA KD cell lines were analyzed using a CTG assay (mean ± SD, n = 3) when cultured with or without Dox. Inducible KD of Rpn10 was achieved using pTRIPz-mCherry vector containing Rpn10-shRNA or scramble control. (C) The stable adding back cell line was achieved when AMO1 Rpn10-iKO cells were transfected with lentivirus-packaged V5-tagged Rpn10 plasmid or empty plasmid (pEV), followed by blasticidin selection. Cell proliferation was measured by a CTG assay (mean ± SD, n = 3). Immunoblot shows the expression levels of Rpn10. Human AMO1 Rpn10-shRNA KD cells (D) or MM.1S Rpn10-shRNA KD cells (E-F) were subcutaneously inoculated into CB17 severe combined immunodeficiency mice. In the early prevention model (D-E), a cohort of mice was treated with an irradiated 0.0625% Dox diet (1-6 mg of Dox per mouse per day) continuously starting 5 days after injection. In the late prevention model (n = 10) (F), mice were treated with an irradiated 0.0625% Dox diet after the tumor became visible and the volume was ∼100 mm3. The average and standard deviation of tumor volume (mm3) are shown vs the time when the tumor was measured (mean tumor volume ± SD). Kaplan-Meier plots show survival in mice (right). Internal blot shows Rpn10 expression of the tumor lysates.

Close Modal

or Create an Account

Close Modal
Close Modal